The cell therapy technologies market is expected to grow more than US$ 5.3 billion by 2026 at a CAGR of 14.2%.
Nevertheless, high cost of cell-based research and low success rate may be a feature which can hamper demand for cell therapy technologies and restrain growth of the target market over the forecast period. Growing adoption of cell therapy technologies in developing countries may be a factor expected to make a lucrative opportunity for development of the universal cell therapy technologies market over the forecast period.

Leave a Reply

Your email address will not be published. Required fields are marked *